P592 A phase 1, double-blind placebo-controlled single-dose study to determine the immune response to systemic and mucosal antigenic challenge in the presence of vedolizumab
2013 ◽
Vol 7
◽
pp. S248
◽
Keyword(s):
Phase 1
◽
2006 ◽
Vol 44
◽
pp. S208-S209
◽
Keyword(s):
2002 ◽
Vol 24
(10)
◽
pp. 1549-1560
◽
Keyword(s):
2020 ◽
Vol 20
(5)
◽
pp. 489-503
Keyword(s):
2013 ◽
Vol 34
(suppl 1)
◽
pp. P3321-P3321
◽
Keyword(s):